AT364093B - Verfahren zur herstellung von neuen peptiden - Google Patents

Verfahren zur herstellung von neuen peptiden

Info

Publication number
AT364093B
AT364093B AT0618975A AT618975A AT364093B AT 364093 B AT364093 B AT 364093B AT 0618975 A AT0618975 A AT 0618975A AT 618975 A AT618975 A AT 618975A AT 364093 B AT364093 B AT 364093B
Authority
AT
Austria
Prior art keywords
producing new
new peptides
peptides
producing
new
Prior art date
Application number
AT0618975A
Other languages
German (de)
English (en)
Other versions
ATA618975A (de
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Priority to AT249180A priority Critical patent/AT373232B/de
Priority to AT249280A priority patent/AT372941B/de
Publication of ATA618975A publication Critical patent/ATA618975A/de
Application granted granted Critical
Publication of AT364093B publication Critical patent/AT364093B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT0618975A 1974-08-09 1975-08-08 Verfahren zur herstellung von neuen peptiden AT364093B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT249180A AT373232B (de) 1974-08-09 1980-05-09 Verfahren zur herstellung von neuen peptiden
AT249280A AT372941B (de) 1974-08-09 1980-05-09 Verfahren zur herstellung von neuen peptiden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438350A DE2438350C3 (de) 1974-08-09 1974-08-09 Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (2)

Publication Number Publication Date
ATA618975A ATA618975A (de) 1981-02-15
AT364093B true AT364093B (de) 1981-09-25

Family

ID=5922833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0618975A AT364093B (de) 1974-08-09 1975-08-08 Verfahren zur herstellung von neuen peptiden

Country Status (15)

Country Link
US (1) US4024248A (US06277897-20010821-C00009.png)
JP (1) JPS5761268B2 (US06277897-20010821-C00009.png)
AT (1) AT364093B (US06277897-20010821-C00009.png)
BE (1) BE832310A (US06277897-20010821-C00009.png)
CA (1) CA1069888A (US06277897-20010821-C00009.png)
CH (1) CH613186A5 (US06277897-20010821-C00009.png)
DE (1) DE2438350C3 (US06277897-20010821-C00009.png)
DK (1) DK148905C (US06277897-20010821-C00009.png)
FR (1) FR2281132A1 (US06277897-20010821-C00009.png)
GB (1) GB1523623A (US06277897-20010821-C00009.png)
IE (1) IE41510B1 (US06277897-20010821-C00009.png)
IL (1) IL47880A (US06277897-20010821-C00009.png)
LU (1) LU73166A1 (US06277897-20010821-C00009.png)
NL (1) NL182051C (US06277897-20010821-C00009.png)
SE (2) SE424184B (US06277897-20010821-C00009.png)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2617646C2 (de) * 1976-04-22 1986-07-31 Hoechst Ag, 6230 Frankfurt Nonapeptid-amide und Decapeptid-amide mit Gonadoliberin-Wirkung, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
GB1524747A (en) * 1976-05-11 1978-09-13 Ici Ltd Polypeptide
DE2735515A1 (de) * 1977-08-06 1979-02-22 Hoechst Ag Verwendung von lh-rh-peptiden als antikonzeptive
FR2450109B1 (fr) * 1977-11-08 1986-03-28 Roussel Uclaf Nouvelle methode de traitement utilisant la lh-rh, ou des agonistes
US4234571A (en) * 1979-06-11 1980-11-18 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
IT1149971B (it) * 1979-06-11 1986-12-10 Syntex Inc Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
HU185535B (en) * 1982-05-25 1985-02-28 Mta Koezponti Hivatala Process for preparing new gonadoliberin derivatives
HU187503B (en) * 1983-03-29 1986-01-28 Magyar Tudomanyos Akademia,Hu Process for preparing gonadoliberine derivatives containing beta-aspartyl group
AT390066B (de) * 1983-03-29 1990-03-12 Richter Gedeon Vegyeszet Verfahren zur herstellung von neuen gonadoliberin-derivaten
DE3411224A1 (de) * 1984-03-27 1985-10-10 Hoechst Ag, 6230 Frankfurt Verfahren zur racematarmen herstellung von peptidzwischenprodukten der gonadorelin- und gonadorelinanaloga-synthese und neue zwischenprodukte bei diesem verfahren
US4775660A (en) * 1984-08-02 1988-10-04 Fernand Labrie Treatment of breast cancer by combination therapy
US4666885A (en) * 1985-02-08 1987-05-19 Fernand Labrie Combination therapy for treatment of female breast cancer
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
HU193093B (en) * 1985-04-16 1987-08-28 Innofinance Process for stimulating sexual activity of birds and domestic mammalians and process for producing spermatocytes for their propagation
HU194280B (en) * 1985-10-22 1988-01-28 Richter Gedeon Vegyeszet Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
ES2077675T3 (es) * 1989-03-10 1995-12-01 Endorecherche Inc Terapia combinada para el tratamiento de enfermedades sensibles a los estrogenos.
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
JPH0235232A (ja) * 1989-06-29 1990-02-05 Nhk Spring Co Ltd 気室と液室を有する圧力容器
ATE170753T1 (de) * 1989-07-07 1998-09-15 Endorecherche Inc Androgenderivate zur hemming der aktivität der sexualsteroide
HUT60139A (en) * 1989-07-07 1992-08-28 Endorecherche Inc Process for producing pharmaceutical composition suitable for treating prostate cancer connected with androgen
CA2029018A1 (en) * 1989-11-01 1991-05-02 Robert P. Millar Analogues of gonadotropin releasing hormone
JPH0474770U (US06277897-20010821-C00009.png) * 1990-10-31 1992-06-30
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US6242421B1 (en) 1997-11-06 2001-06-05 Richard Lloyd Bowen Methods for preventing and treating Alzheimer's disease
ES2154590B1 (es) 1999-05-20 2001-11-01 Lipotec Sa Procedimiento de sintesis de peptidos en fase solida
AR023940A1 (es) 2000-05-03 2002-09-04 Eriochem Sa Procedimiento para la produccion de microcapsulas de liberacion prolongada de peptidos solubles en agua
CA2451187C (en) 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
US20060287282A1 (en) * 2001-06-25 2006-12-21 Steiner Mitchell S Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
JP2003137814A (ja) * 2001-08-10 2003-05-14 Takeda Chem Ind Ltd ＧｎＲＨアゴニストの併用剤
WO2003041739A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticaner agents
US20030144203A1 (en) * 2001-12-19 2003-07-31 Voyager Pharmaceutical Corporation Methods for slowing senescence and treating and preventing diseases associated with senescence
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2959893A1 (en) 2002-12-13 2015-12-30 DURECT Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
GB0307777D0 (en) * 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
PL1809329T3 (pl) 2004-09-17 2012-08-31 Durect Corp Kompozycja znieczulająca zawierająca saib o przedłużonym uwalnianiu do stosowania miejscowego
MX2007008781A (es) 2005-01-21 2007-09-11 Astex Therapeutics Ltd Compuestos farmaceuticos.
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US7942867B2 (en) * 2005-11-09 2011-05-17 The Invention Science Fund I, Llc Remotely controlled substance delivery device
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
WO2009088414A2 (en) 2007-12-06 2009-07-16 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
RU2444525C2 (ru) * 2010-06-09 2012-03-10 Закрытое Акционерное Общество "Фарм-Синтез" Способ получения нонапептидэтиламида и промежуточные соединения для его получения
BR112012032189B1 (pt) 2010-06-16 2020-11-03 Endorecherche, Inc usos de um agonista ou antagonista de lhrh em associação com um modulador de receptor de estrogênio seletivo e com um precursor de esteróide sexual para a preparação de uma medicamento para o tratamento ou prevenção de doenças relacionadas com estrogênio e kits
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5726506B2 (US06277897-20010821-C00009.png) * 1974-03-08 1982-06-04
US3914412A (en) * 1973-10-11 1975-10-21 Abbott Lab {8 Des{13 Gly{9 {0 10 -Gn{13 RH nonapeptide amide analogs in position 6 having ovulation-inducing activity
US3901872A (en) * 1974-03-13 1975-08-26 American Home Prod P-glu-his-trp-ser-tyr-d-pgl-leu-arg-pro-gly-nh' 2 'and intermediates
US3896104A (en) * 1974-05-22 1975-07-22 American Home Prod P-glu-his-trp-ser-tyr-d-lys-leu-arg-pro-gly-nh' 2 'and intermediates

Also Published As

Publication number Publication date
AU8374475A (en) 1977-02-10
DK361875A (da) 1976-02-10
US4024248A (en) 1977-05-17
IE41510L (en) 1976-02-09
FR2281132A1 (fr) 1976-03-05
IE41510B1 (en) 1980-01-16
GB1523623A (en) 1978-09-06
NL182051B (nl) 1987-08-03
JPS5761268B2 (US06277897-20010821-C00009.png) 1982-12-23
CH613186A5 (US06277897-20010821-C00009.png) 1979-09-14
JPS5148659A (US06277897-20010821-C00009.png) 1976-04-26
SE7805545L (US06277897-20010821-C00009.png) 1978-05-16
SE424184B (sv) 1982-07-05
ATA618975A (de) 1981-02-15
FR2281132B1 (US06277897-20010821-C00009.png) 1979-09-14
NL7509260A (nl) 1976-02-11
CA1069888A (en) 1980-01-15
IL47880A (en) 1978-10-31
LU73166A1 (US06277897-20010821-C00009.png) 1977-04-13
DK148905B (da) 1985-11-11
IL47880A0 (en) 1975-11-25
DE2438350B2 (de) 1978-10-26
DE2438350A1 (de) 1976-02-26
DE2438350C3 (de) 1979-06-13
DK148905C (da) 1986-04-07
NL182051C (nl) 1988-01-04
SE7508926L (sv) 1976-02-10
BE832310A (fr) 1976-02-11

Similar Documents

Publication Publication Date Title
AT364093B (de) Verfahren zur herstellung von neuen peptiden
AT353992B (de) Verfahren zur herstellung von neuen peptiden
AT344890B (de) Verfahren zur herstellung von neuen 6-thiatetracyclinen
AT360674B (de) Verfahren zur herstellung von neuen peptiden
AT366026B (de) Verfahren zur herstellung von neuen peptiden
AT343632B (de) Verfahren zur herstellung von neuen l- oder dl-tyrosinamiden
AT359219B (de) Verfahren zur herstellung von neuen peptiden
AT344333B (de) Verfahren zur herstellung von neuen 8-thiomethylergolinen
AT348540B (de) Verfahren zur herstellung von neuen substituierten phenylguanidinen
AT350529B (de) Verfahren zur herstellung von neuen acylaminophenylalkylaminen
AT343675B (de) Verfahren zur herstellung von neuen biguaniden
ATA428075A (de) Verfahren zur herstellung von neuen 1-aethyl-3a-metasubstituiertes-phenyl-decahydroisochinolinen
AT348161B (de) Verfahren zur herstellung von neuen peptiden
AT357998B (de) Verfahren zur herstellung von neuen bis-0- -sulfamoylglykolen
AT347935B (de) Verfahren zur herstellung von neuen 2-carbalk- oxyamino-5(6)-phenylsulfonyloxy-benzimidazolen
AT342590B (de) Verfahren zur herstellung von neuen 2-amino-6-dialkylaminodihydropyridinen
AT348153B (de) Verfahren zur herstellung von neuen polypeptiden
AT342046B (de) Verfahren zur herstellung von neuen n-benzylaminooxazolinen
AT341539B (de) Verfahren zur herstellung von neuen 3-amino-2beta-thiohydrazoazetidinonen
AT340070B (de) Verfahren zur herstellung von neuen peptiden
AT349160B (de) Verfahren zur herstellung von neuen bufatrienolidrhamnosidaethern
AT346362B (de) Verfahren zur herstellung von neuen 3-alkyl-7- (omega-1)-oxoalkylxanthinen
AT348697B (de) Verfahren zur herstellung von neuen d- homosteroiden
AT357697B (de) Verfahren zur herstellung von neuen polypeptiden
AT372941B (de) Verfahren zur herstellung von neuen peptiden

Legal Events

Date Code Title Description
ELA Expired due to lapse of time